A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 33 (11), 1610-1613
- https://doi.org/10.1016/s0022-3468(98)90591-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Use of extracorporeal membrane oxygenation in the septic neonateJournal of Pediatric Surgery, 1995
- Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMOJournal of Pediatric Surgery, 1993
- Natural and synthetic antifibrinolytics in cardiac surgeryCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1992
- Letter to the editor: Changes in fibrinolytic factors in newborns during extracorporeal membrane oxygenation (ECMO)American Journal of Hematology, 1991
- Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia.Stroke, 1990
- Newborn's fibrinolytic mechanism: Components and plasmin generationAmerican Journal of Hematology, 1989
- Hemostasis Defects Associated with Cardiac Surgery, Prosthetic Devices, and Other Extracorporeal CircuitsSeminars in Thrombosis and Hemostasis, 1985
- Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acidThe Journal of Pediatrics, 1981
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978
- Epsilon-Aminocaproic Acid for Bleeding After Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1971